Angiotensin-(1-7) upregulates expression of adenosine triphosphate-binding cassette transporter A1 and adenosine triphosphate-binding cassette transporter G1 through the Mas receptor through the liver X receptor alpha signalling pathway in THP-1 macrophages treated with angiotensin-II

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 12, 2014, Pages 1023-1030

  Liang, Bin ^a   Wang, Xin ^a   Bian, Yunfei ^a   Yang, Huiyu ^a   Liu, Ming ^a   Bai, Rui ^a   Yang, Zhiming ^a   Xiao, Chuanshi ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Adenosine triphosphate binding cassette transporter A1; Adenosine triphosphate binding cassette transporter G1; Angiotensin (1 7); Liver X receptor ; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; ANGIOTENSIN II; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; APOLIPOPROTEIN A1; CHOLESTEROL; LIVER X RECEPTOR ALPHA; MAS RECEPTOR; MESSENGER RNA; RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIQUID SCINTILLATION COUNTING; MACROPHAGE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 84912534705     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12312     Document Type: Article

References (24)

1. Choudhury RP, Lee JM, Greaves DR. Mechanisms of disease: Macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis. Nat. Clin. Pract. Cardiovasc. Med. 2005; 2: 309-15.
2. Yuan Y, Li P, Ye J. Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis. Protein Cell 2012; 3: 173-81.
3. Escola-Gil JC, Rotllan N, Julve J, Blanco-Vaca F. In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection. Atherosclerosis 2009; 206: 321-7.
4. Lee CH, Tai BC, Lim GH et al. Correlation between high density lipoprotein-cholesterol and remodeling index in patients with coronary artery disease: IDEAS (IVUS diagnostic evaluation of atherosclerosis in Singapore)-HDL study. Int. J. Cardiovasc. Imaging 2012; 28: 33-41.
5. Rosenson RS, Brewer HB Jr, Davidson WS et al. Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport. Circulation 2012; 125: 1905-19.
6. Fitzgerald ML, Mujawar Z, Tamehiro N. ABC transporters, atherosclerosis and inflammation. Atherosclerosis 2010; 211: 361-70.
7. Schmitz G, Langmann T. Structure, function and regulation of the ABC1 gene product. Curr. Opin. Lipidol. 2001; 12: 129-40.
8. Delvecchio CJ, Bilan P, Nair P, Capone JP. LXR-induced reverse cholesterol transport in human airway smooth muscle is mediated exclusively by ABCA1. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008; 295: L949-57.
9. Xu X, Li Q, Pang L et al. Arctigenin promotes cholesterol efflux from THP-1 macrophages through PPAR-gamma/LXR-alpha signaling pathway. Biochem. Biophys. Res. Commun. 2013; 441: 321-6.
10. Takata Y, Chu V, Collins AR et al. Transcriptional repression of ATP-binding cassette transporter A1 gene in macrophages: A novel atherosclerotic effect of angiotensin II. Circ. Res. 2005; 97: e88-96.
11. Wang Y, Chen Z, Liao Y et al. Angiotensin II increases the cholesterol content of foam cells via down-regulating the expression of ATP-binding cassette transporter A1. Biochem. Biophys. Res. Commun. 2007; 353: 650-4.
12. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996; 28: 104-8.
13. Loot AE, Roks AJ, Henning RH et al. Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 2002; 105: 1548-50.
14. Tallant EA, Clark MA. Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension 2003; 42: 574-9.
15. Prasannarong M, Santos FR, Henriksen EJ. ANG-(1-7) reduces ANGII-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle. Biochem. Biophys. Res. Commun. 2012; 426: 369-73.
16. Wang L, Hu X, Zhang W, Tian F. Angiotensin (1-7) ameliorates angiotensin II-induced inflammation by inhibiting LOX-1 expression. Inflamm. Res. 2013; 62: 219-28.
17. Yang HY, Bian YF, Zhang HP et al. Angiotensin-(1-7) treatment ameliorates angiotensin II-induced apoptosis of human umbilical vein endothelial cells. Clin. Exp. Pharmacol. Physiol. 2012; 39: 1004-10.
18. Chen SG, Xiao J, Liu XH et al. Ibrolipim increases ABCA1/G1 expression by the LXRα signaling pathway in THP-1 macrophage-derived foam cells. Acta Pharmacol. Sin. 2010; 31: 1343-9.
19. Scheidegger KJ, Butler S, Witztum JL. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway. J. Biol. Chem. 1997; 272: 21609-15.
20. Diep QN, Amiri F, Touyz RM et al. PPARalpha activator effects on AngII-induced vascular oxidative stress and inflammation. Hypertension 2002; 40: 866-71.
21. Pettersson AM, Stenson BM, Lorente-Cebrian S et al. LXR is a negative regulator of glucose uptake in human adipocytes. Diabetologia 2013; 56: 2044-54.
22. Aravindhan K, Webb CL, Jaye M et al. Assessing the effects of LXR agonists on cellular cholesterol handling: A stable isotope tracer study. J. Lipid Res. 2006; 47: 1250-60.
23. Ferreira AJ, Santos RA, Almeida AP. Angiotensin-(1-7): Cardioprotective effect in myocardial ischemia/reperfusion. Hypertension 2001; 38: 665-8.
24. Santos RA, Simoes e Silva AC, Maric C et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 2003; 100: 8258-63.